BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.

Investors remain optimistic about Boston Scientific due to its geographical expansions and impressive acquisitions.

In a report released on November 15, David Rescott from Robert W. Baird maintained a Buy rating on Boston Scientific (BSX – Research Report), ...

Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on BSX stock, giving a Buy rating yesterday.Don't Miss our Black ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global ...

The attack came just days after President Biden gave Ukraine permission to use the weapons to strike targets inside Russia. By Marc Santora and Eric Schmitt The envoy, Amos Hochstein, said an ...

Footage of a man being shoved into a wall by a police officer before being dragged through a front yard has been shared on social media, with SA Police confirming a formal complaint has been made ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...

Sequent Scientific Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 4,660.69 Crore) operating in Pharmaceuticals sector. Sequent Scientific Ltd. key ...